Journal
FRONTIERS IN PHARMACOLOGY
Volume 6, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2015.00079
Keywords
obesity; inflammation; cytokines; resveratrol; transcriptional activation; adipocytes; white
Categories
Funding
- Margarete von Wrangell scholarship
- Baden-Wuerttemberg Ministry of Science, Research and Arts
- European Social Fund
- Ulm University
- International Gradute School in Molecular Medicine Ulm
- foundation Das zuckerkranke Kind
- Bioccnter Oulu, Academy of Finland
- Sigrid jusclius Foundation
Ask authors/readers for more resources
Obesity is associated with an inflammatory status and linked with a number of pathophysiological complications among them cardiovascular disease, type 2 diabetes mellitus, or the metabolic syndrome. Resveratrol was proposed to improve obesityrelated inflammatory problems, but the effect of resveratrol on cytokine expression in obesity is not completely understood. In this study, we used an in vitro model of human adipose tissue inflammation to examine the effects of resveratrol on the production of the inflammatory cytokines interleukin 6 (IL-6), IL-8, and monocyte chemoattractant protein 1 (MCP-1). We found that resveratrol reduced IL-6, IL-8, and MCP-1 levels in a concentration-dependent manner in adipocytes under inflammatory conditions. Further experiments showed that the action of resveratrol was mainly due to its NFKB inhibitory potential. Thus, our data support the concept that resveratrol can alleviate obesityinduced up-regulation of inflammatory cytokines providing a new insight toward novel treatment options in obesity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available